Discovery of first-in-class thiazole-based dual FFA1/PPARδ agonists as potential anti-diabetic agents
摘要:
The free fatty acid receptor 1 (FFA1 or GPR40) and peroxisome proliferator-activated receptor delta (PPAR delta) have attracted a lot of attention due to their role in promoting insulin secretion and sensibility, respectively, which are two major features of diabetes. Therefore, the dual FFA1/PPAR delta agonists would increase insulin secretion and sensibility by FFA1 and PPAR delta activation. In this study, we hybrid FFA1 agonist AM-4668 with PPAR delta agonist GW501516, leading to the identification of orally bioavailable dual agonist 32, which revealed high selectivity over other PPAR delta. Moreover, compound 32 exhibited good pharmacokinetic profiles with high plasma concentration, sustained half-life and low clearance in vivo. During the hypoglycemic test, a dual agonist 32 enhanced the tolerance of ob/ob mice for glucose loading in a dose-dependent manner. Our results suggest that dual FFA1/PPAR delta agonist could be a valuable therapy for type 2 diabetes. (C) 2018 Elsevier Masson SAS. All rights reserved.
Rh(I)-Catalyzed Arylation of Heterocycles via C−H Bond Activation: Expanded Scope through Mechanistic Insight
作者:Jared C. Lewis、Ashley M. Berman、Robert G. Bergman、Jonathan A. Ellman
DOI:10.1021/ja0748985
日期:2008.2.1
A practical, functional group tolerant method for the Rh-catalyzed direct arylation of a variety of pharmaceutically important azoles with aryl bromides is described. Many of the successful azole and aryl bromide coupling partners are not compatible with methods for the direct arylation of heterocycles using Pd(0) or Cu(I) catalysts. The readily prepared, low molecular weight ligand, Z-1-tert-butyl-2
Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
申请人:Maeda Dean Y.
公开号:US20100210593A1
公开(公告)日:2010-08-19
There is disclosed pyridine- and pyrimidinecarboxamide compounds useful as pharmaceutical agents, synthesis processes, and pharmaceutical compositions which include pyridine- and pyrimidinecarboxamides compounds. More specifically, there is disclosed a genus of CXCR2 inhibitor compounds that are useful for treating a variety of inflammatory and neoplastic disorders.
compounds were fully characterized by 1H, 13C1H} NMR and FT-IR spectra. The structures of 2c, 2d, and 2e were determined by X-ray crystallography and the prepared complexes (2a-e) were investigated as catalysts for the direct arylation of 2-n-propylthiazole, 4,5-dimethylthiazole and 2-acetylthiophene with various aryl bromides. High catalytic activity for arylation was seen reaction using only 0.5 mol%
在富含电子的杂芳烃的情况下,可以使用芳基卤化物活化特定的C H键进行芳基化,而无需指导该基团。容易产生卤素取代的芳基化杂芳烃的能力在有机化学中很重要,因为这些物种是生物化学家的重要组成部分。在此手稿中,我们报告了PEPPSI型新型苯并咪唑基N-杂环卡宾-钯(II)配合物(2a-e)的合成。所有这些新化合物均通过1 H,13 C 1 H} NMR和FT-IR光谱进行了全面表征。通过X射线晶体学确定2c,2d和2e的结构,并制备配合物(研究了2a-e)作为2-正丙基噻唑,4,5-二甲基噻唑和2-乙酰基噻吩与各种芳基溴直接芳基化的催化剂。仅使用0.5mol%的催化剂反应1小时,观察到高的芳基化催化活性。
Palladium(II)- N -heterocyclic carbene-catalyzed direct C2- or C5-arylation of thiazoles with aryl bromides
作者:Murat Kaloğlu、İsmail Özdemir
DOI:10.1016/j.tet.2018.03.026
日期:2018.6
their corresponding palladium(II)-NHC complexes with the general formula [PdCl2(NHC)2] were synthesized. All new compounds were characterized by 1H NMR, 13C NMR, IR spectroscopy and elemental analysis techniques. The catalytic activity of palladium(II)-NHC complexes was investigated in the direct C2- or C5-arylation of thiazoles with aryl bromides in presence of palladium(II)-NHC at 150 °C for 1 h. These
在此我们报道,合成了一系列新的苯并咪唑氯化物作为N-杂环卡宾(NHC)配体及其相应的通式为[PdCl 2(NHC)2 ]的钯(II)-NHC配合物。所有新化合物均通过1 H NMR,13 C NMR,IR光谱和元素分析技术进行表征。在钯(II)-NHC的存在下于150°C进行1 h的噻唑与芳基溴的直接C2-或C5-芳基化反应中,研究了钯(II)-NHC配合物的催化活性。这些配合物对噻唑直接芳基化表现出良好的催化性能。噻唑的芳基化以中等至高产率选择性地产生C 2或C 5芳基化的噻唑。